2021
DOI: 10.1016/j.anndiagpath.2021.151729
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic value of FUS immunoexpression for Gleason patterns and prostatic adenocarcinoma progression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 29 publications
0
3
0
Order By: Relevance
“…FUS is a member of the FET/TET protein family and is closely related to the pathogenesis of PRAD. Gleason pattern analysis also found that the frequency of FUS positive in nontumor tissues was lower than in PRAD tumor tissues [ 1 ]. Studies have found that low FUS expression in prostate cancer cell lines VCaP and LNCaP can phenomenally inhibit the expression of androgen AR and its downstream targets IGF1R and EGFR, thus inhibiting PRAD proliferation [ 19 ].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…FUS is a member of the FET/TET protein family and is closely related to the pathogenesis of PRAD. Gleason pattern analysis also found that the frequency of FUS positive in nontumor tissues was lower than in PRAD tumor tissues [ 1 ]. Studies have found that low FUS expression in prostate cancer cell lines VCaP and LNCaP can phenomenally inhibit the expression of androgen AR and its downstream targets IGF1R and EGFR, thus inhibiting PRAD proliferation [ 19 ].…”
Section: Discussionmentioning
confidence: 99%
“…Prostate adenocarcinoma (PRAD) is the most common tumor in men, with high morbidity and mortality [ 1 , 2 ]. Surgery and chemotherapy are the main means of PRAD treatment, but the recurrence rate is high, and the prognosis is poor [ 3 , 4 ].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation